REGISTERED NUMBER: 13208428 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2025

FOR

BLOOMFIELD HEALTH LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr M A P Hambrook Bloomfield

Dr D G P Hambrook Bloomfield

S H Jones

REGISTERED OFFICE:

The Stables

23b Lenten Street

Alton

Hampshire

GU34 1HG

REGISTERED NUMBER:

13208428 (England and Wales)

ACCOUNTANTS:

LFM

Chartered Certified Accountants

The Stables

23b Lenten Street

Alton

Hampshire

GU34 1HG

FIXED ASSETS

Tangible assets

4

4,815

1,996

CURRENT ASSETS

Debtors

5

63,989

83,974

Cash at bank

19,333

7,385

83,322

91,359

CREDITORS

Amounts falling due within one year

6

86,638

58,398

NET CURRENT (LIABILITIES)/ASSETS

(3,316

)

32,961

TOTAL ASSETS LESS CURRENT LIABILITIES

1,499

34,957

PROVISIONS FOR LIABILITIES

1,204

459

NET ASSETS

295

34,498

CAPITAL AND RESERVES

Called up share capital

1

1

Retained earnings

294

34,497

SHAREHOLDERS' FUNDS

295

34,498

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 November 2025 and were signed on its behalf by:

Dr M A P Hambrook Bloomfield - Director

1.	STATUTORY INFORMATION

Bloomfield Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2024 - 8 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 29 February 2024

4,107

Additions

5,136

At 28 February 2025

9,243

DEPRECIATION

At 29 February 2024

2,111

Charge for year

2,317

At 28 February 2025

4,428

NET BOOK VALUE

At 28 February 2025

4,815

At 28 February 2024

1,996

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

25,258

20,633

Other debtors

38,731

63,341

63,989

83,974

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

4,050

1,834

Amounts owed to group undertakings

1,200

1,284

Taxation and social security

36,485

29,828

Other creditors

44,903

25,452

86,638

58,398

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 28 February 2025 and 28 February 2024:

2025

2024

£

£

Dr M A P Hambrook Bloomfield and Dr D G P Hambrook Bloomfield

Balance outstanding at start of year

62,978

32,794

Amounts advanced

111,198

102,652

Amounts repaid

(135,759

)

(72,468

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

38,417

62,978

Interest was charged on the overdrawn balance at a rate of 2.25% per annum. Interest totalled £949 (2024: £761) in the financial year.

The loan was repaid within 9 months of the year end.

8.	ULTIMATE CONTROLLING PARTY

The controlling party is Bloomfield Health Holdings Ltd.

The ultimate controlling party is Dr M A P Hambrook Bloomfield.